April 30, 2026 Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
April 30, 2026 Pepeto Announces AI Tools Update While XRP and Cardano Debate of Best Crypto to Buy Now Accelerates Through The Crypto News
April 30, 2026 MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update